Precigen
PGEN
168 hedge funds and large institutions have $2.81B invested in Precigen in 2016 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 70 increasing their positions, 45 reducing their positions, and 20 closing their positions.
56% more repeat investments, than reductions
Existing positions increased: 70 | Existing positions reduced: 45
15% more capital invested
Capital invested by funds: $2.45B → $2.81B (+$363M)
8% more call options, than puts
Call options by funds: $56.1M | Put options by funds: $51.9M
0.78% more ownership
Funds ownership: 84.92% → 85.7% (+0.78%)
0% more funds holding in top 10
Funds holding in top 10: 5 → 5 (0)
1% less funds holding
Funds holding: 169 → 168 (-1)
5% less first-time investments, than exits
New positions opened: 19 | Existing positions closed: 20
Top Buyers
Top Sellers
| 1 |
AQR Capital Management
Greenwich,
Connecticut
|
-$7.4M |
| 2 |
Wells Fargo
San Francisco,
California
|
-$7.18M |
| 3 |
Morgan Stanley
New York
|
-$5.85M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$3.15M |
| 5 |
SM
Sabby Management
Miami Beach,
Florida
|
-$2.96M |
PGEN Hedge Fund Activity: Q3 2016 in Review
168 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Precigen (PGEN) for Q3 2016, worth a combined $2.81B — up 15% from $2.45B a quarter earlier.
Sellers outnumbered buyers: 20 funds closed out of PGEN and 19 opened new positions — a net loss of 1 holder — while 45 trimmed existing stakes and 70 added.
The largest buyer was First Trust Advisors, adding an estimated $20.3M. The largest seller was AQR Capital Management, cutting an estimated $7.4M.
- 168 institutional investors held Precigen (PGEN) as of Q3 2016, down from 169 in Q2 2016.
- Funds reported $2.81B of Precigen stock for Q3 2016, up 15% quarter-over-quarter.
- 19 funds opened new Precigen positions in Q3 2016 and 20 closed out, a net change of -1 holder.
- The largest Precigen buyer in Q3 2016 was First Trust Advisors, an estimated $20.3M added.
- The largest Precigen seller in Q3 2016 was AQR Capital Management, an estimated $7.4M sold.
Based on aggregated 13F filings for Q3 2016.